Skip to main content
PMC home page
Applied and Environmental Microbiology logoLink to Applied and Environmental Microbiology
. 1995 Apr;61(4):1475–1479. doi: 10.1128/aem.61.4.1475-1479.1995

The lysostaphin endopeptidase resistance gene (epr) specifies modification of peptidoglycan cross bridges in Staphylococcus simulans and Staphylococcus aureus.

H P DeHart 1, H E Heath 1, L S Heath 1, P A LeBlanc 1, G L Sloan 1
PMCID: PMC167404  PMID: 7747966

Abstract

Staphylococcus simulans biovar staphylolyticus produces an extracellular glycylglycine endopeptidase (lysostaphin) that lyses other staphylococci by hydrolyzing the cross bridges in their cell wall peptidoglycans. The genes for endopeptidase (end) and endopeptidase resistance (epr) reside on plasmid pACK1. An 8.4-kb fragment containing end was cloned into shuttle vector pL150 and was then introduced into Staphylococcus aureus RN4220. The recombinant S. aureus cells produced endopeptidase and were resistant to lysis by the enzyme, which indicated that the cloned fragment also contained epr. Treatments to remove accessory wall polymers (proteins, teichoic acids, and lipoteichoic acids) did not change the endopeptidase sensitivity of walls from strains of S. simulans biovar staphylolyticus or of S. aureus with and without epr. Immunological analyses of various wall fractions showed that there were epitopes associated with endopeptidase resistance and that these epitopes were found only on the peptidoglycans of epr+ strains of both species. Treatment of purified peptidoglycans with endopeptidase confirmed that resistance or susceptibility of both species was a property of the peptidoglycan itself. A comparison of the chemical compositions of these peptidoglycans revealed that cross bridges in the epr+ cells contained more serine and fewer glycine residues than those of cells without epr. The presence of the 8.4-kb fragment from pACK1 also increased the susceptibility of both species to methicillin.

Full Text

The Full Text of this article is available as a PDF (209.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amako K., Umeda A., Murata K. Arrangement of peptidoglycan in the cell wall of Staphylococcus spp. J Bacteriol. 1982 May;150(2):844–850. doi: 10.1128/jb.150.2.844-850.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Araki Y., Nakatani T., Nakayama K., Ito E. Occurrence of N-nonsubstituted glucosamine residues in peptidoglycan of lysozyme-resistant cell walls from Bacillus cereus. J Biol Chem. 1972 Oct 10;247(19):6312–6322. [PubMed] [Google Scholar]
  3. BROWDER H. P., ZYGMUNT W. A., YOUNG J. R., TAVORMINA P. A. LYSOSTAPHIN: ENZYMATIC MODE OF ACTION. Biochem Biophys Res Commun. 1965 Apr 23;19:383–389. doi: 10.1016/0006-291x(65)90473-0. [DOI] [PubMed] [Google Scholar]
  4. Bierbaum G., Sahl H. G. Autolytic system of Staphylococcus simulans 22: influence of cationic peptides on activity of N-acetylmuramoyl-L-alanine amidase. J Bacteriol. 1987 Dec;169(12):5452–5458. doi: 10.1128/jb.169.12.5452-5458.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Clarke A. J. Extent of peptidoglycan O acetylation in the tribe Proteeae. J Bacteriol. 1993 Jul;175(14):4550–4553. doi: 10.1128/jb.175.14.4550-4553.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cleveland R. F., Holtje J. V., Wicken A. J., Tomasz A., Daneo-Moore L., Shockman G. D. Inhibition of bacterial wall lysins by lipoteichoic acids and related compounds. Biochem Biophys Res Commun. 1975 Dec 1;67(3):1128–1135. doi: 10.1016/0006-291x(75)90791-3. [DOI] [PubMed] [Google Scholar]
  7. Donegan E. A., Riggs H. G., Jr In vitro incorporation of serine into the staphylococcal cell wall. Infect Immun. 1974 Jul;10(1):264–269. doi: 10.1128/iai.10.1.264-269.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dower W. J., Miller J. F., Ragsdale C. W. High efficiency transformation of E. coli by high voltage electroporation. Nucleic Acids Res. 1988 Jul 11;16(13):6127–6145. doi: 10.1093/nar/16.13.6127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fischer W., Rösel P., Koch H. U. Effect of alanine ester substitution and other structural features of lipoteichoic acids on their inhibitory activity against autolysins of Staphylococcus aureus. J Bacteriol. 1981 May;146(2):467–475. doi: 10.1128/jb.146.2.467-475.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. GHUYSEN J. M., STROMINGER J. L. STRUCTURE OF THE CELL WALL OF STAPHYLOCOCCUS AUREUS, STRAIN COPENHAGEN. II. SEPARATION AND STRUCTURE OF DISACCHARIDES. Biochemistry. 1963 Sep-Oct;2:1119–1125. doi: 10.1021/bi00905a036. [DOI] [PubMed] [Google Scholar]
  11. Giudicelli S., Tomasz A. Attachment of pneumococcal autolysin to wall teichoic acids, an essential step in enzymatic wall degradation. J Bacteriol. 1984 Jun;158(3):1188–1190. doi: 10.1128/jb.158.3.1188-1190.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. HEYMANN H., MANNIELLO J. M., BARKULIS S. S. STRUCTURE OF STREPTOCOCCAL CELL WALLS. 3. CHARACTERIZATION OF AN ALANINE-CONTAINING GLUCOSAMINYLMURAMIC ACID DERIVATIVE LIBERATED BY LYSOZYME FROM STREPTOCOCCAL GLYCOPEPTIDE. J Biol Chem. 1964 Sep;239:2981–2985. [PubMed] [Google Scholar]
  13. Hayashi H., Araki Y., Ito E. Occurrence of glucosamine residues with free amino groups in cell wall peptidoglycan from bacilli as a factor responsible for resistance to lysozyme. J Bacteriol. 1973 Feb;113(2):592–598. doi: 10.1128/jb.113.2.592-598.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Heath H. E., Heath L. S., Nitterauer J. D., Rose K. E., Sloan G. L. Plasmid-encoded lysostaphin endopeptidase resistance of Staphylococcus simulans biovar staphylolyticus. Biochem Biophys Res Commun. 1989 May 15;160(3):1106–1109. doi: 10.1016/s0006-291x(89)80117-2. [DOI] [PubMed] [Google Scholar]
  15. Henze U., Sidow T., Wecke J., Labischinski H., Berger-Bächi B. Influence of femB on methicillin resistance and peptidoglycan metabolism in Staphylococcus aureus. J Bacteriol. 1993 Mar;175(6):1612–1620. doi: 10.1128/jb.175.6.1612-1620.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Herbold D. R., Glaser L. Bacillus subtilis N-acetylmuramic acid L-alanine amidase. J Biol Chem. 1975 Mar 10;250(5):1676–1682. [PubMed] [Google Scholar]
  17. Herbold D. R., Glaser L. Interaction of N-acetylmuramic acid L-alanine amidase with cell wall polymers. J Biol Chem. 1975 Sep 25;250(18):7231–7238. [PubMed] [Google Scholar]
  18. Korman R. Z. Elevated cell wall serine in pleiotropic staphylococcal mutants. J Bacteriol. 1966 Sep;92(3):762–768. doi: 10.1128/jb.92.3.762-768.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Maidhof H., Reinicke B., Blümel P., Berger-Bächi B., Labischinski H. femA, which encodes a factor essential for expression of methicillin resistance, affects glycine content of peptidoglycan in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains. J Bacteriol. 1991 Jun;173(11):3507–3513. doi: 10.1128/jb.173.11.3507-3513.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Martin J. P., Fleck J., Mock M., Ghuysen J. M. The wall peptidoglycans of Neisseria perflava, Moraxella glucidolytica, Pseudomonas alcaligenes and Proteus vulgaris strain P18. Eur J Biochem. 1973 Oct 5;38(2):301–306. doi: 10.1111/j.1432-1033.1973.tb03062.x. [DOI] [PubMed] [Google Scholar]
  21. Neumann V. C., Heath H. E., LeBlanc P. A., Sloan G. L. Extracellular proteolytic activation of bacteriolytic peptidoglycan hydrolases of Staphylococcus simulans biovar staphylolyticus. FEMS Microbiol Lett. 1993 Jun 15;110(2):205–211. doi: 10.1111/j.1574-6968.1993.tb06321.x. [DOI] [PubMed] [Google Scholar]
  22. Novick R. P. Genetic systems in staphylococci. Methods Enzymol. 1991;204:587–636. doi: 10.1016/0076-6879(91)04029-n. [DOI] [PubMed] [Google Scholar]
  23. Robinson J. M., Hardman J. K., Sloan G. L. Relationship between lysostaphin endopeptidase production and cell wall composition in Staphylococcus staphylolyticus. J Bacteriol. 1979 Mar;137(3):1158–1164. doi: 10.1128/jb.137.3.1158-1164.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Robinson J. M., Heath H. E., Sloan G. L. Lack of pleiotropic compensation in extracellular protein production by hypoproducing variants of Staphylococcus simulans biovar staphylolyticus. J Gen Microbiol. 1987 Feb;133(2):253–257. doi: 10.1099/00221287-133-2-253. [DOI] [PubMed] [Google Scholar]
  25. Rosenthal R. S., Blundell J. K., Perkins H. R. Strain-related differences in lysozyme sensitivity and extent of O-acetylation of gonococcal peptidoglycan. Infect Immun. 1982 Aug;37(2):826–829. doi: 10.1128/iai.37.2.826-829.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Williamson C. M., Bramley A. J., Lax A. J. Expression of the lysostaphin gene of Staphylococcus simulans in a eukaryotic system. Appl Environ Microbiol. 1994 Mar;60(3):771–776. doi: 10.1128/aem.60.3.771-776.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Zygmunt W. A., Browder H. P., Tavormina P. A. Lytic action of lysostaphin on susceptible and resistant strains of Staphylococcus aureus. Can J Microbiol. 1967 Jul;13(7):845–853. doi: 10.1139/m67-111. [DOI] [PubMed] [Google Scholar]
  28. de Jonge B. L., Sidow T., Chang Y. S., Labischinski H., Berger-Bachi B., Gage D. A., Tomasz A. Altered muropeptide composition in Staphylococcus aureus strains with an inactivated femA locus. J Bacteriol. 1993 May;175(9):2779–2782. doi: 10.1128/jb.175.9.2779-2782.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Applied and Environmental Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES